Zeposia (Ozanimod) for Multiple Sclerosis | MyMSTeam

Connect with others who understand.

sign up Log in
About MyMSTeam
Powered By

Zeposia is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat relapsing forms of multiple sclerosis (MS) in adults, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. Zeposia is also known by its drug name, ozanimod.

Zeposia is an immunomodulator, or a drug that affects the functioning of the immune system. It is believed to work by binding to receptors in lymph nodes and blocking the release of immune cells into tissues in the central nervous system (brain and spinal cord), thereby preventing inflammation and nerve damage that may cause symptoms of multiple sclerosis.

How do I take it?
Zeposia is taken orally as prescribed by a physician.

Zeposia comes in the form of hard gelatin capsules.

Side effects
The FDA-approved label for Zeposia lists common side effects including upper respiratory infection, elevated levels of certain liver enzymes (hepatic transaminases), low or high blood pressure, urinary tract infection, and back pain.

Rare but serious side effects can include liver damage, decline in pulmonary function, decrease in heart rate, and a buildup of fluid in an area in the center of the retina (macular edema). If you are pregnant or planning to become pregnant, consult your doctor before taking Zeposia.

For more information about this treatment, visit:

Zeposia — Bristol Myers Squibb

Zeposia (Ozanimod) — Multiple Sclerosis News Today

Continue with Facebook
Continue with Google
Lock Icon Your privacy is our priority. By continuing, you accept our Terms of use, and our Health Data and Privacy policies.
Already a Member? Log in